{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:58:10Z","timestamp":1789441090860,"version":"build-2803163510"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This study investigated the association between thyroid disorders and breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective case-control study was conducted using electronic health record data from an academic health care system. This study included 300 female patients 18 years of age and older with a diagnosis of breast cancer and 300 control individuals with no cancer history. Statistical analysis included calculation of prevalence and odds ratios for association, \uab532 for categorical variables, and mean (SD) and median for age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with breast cancer were, on average, 58 years old, statistically significantly older than patients without cancer (P\u2005&amp;lt;\u2005.001). Patients were 6 times more likely to have thyroid disorders (P\u2005&amp;lt;\u2005.001), including hypothyroidism (P\u2005&amp;lt;\u2005.001), than women who did not have cancer. Patients with triple-negative breast cancer had 4 times higher odds of being diagnosed with thyroid disorders overall (P\u2005&amp;lt;\u2005.001) and hypothyroidism (P\u2005&amp;lt;\u2005.001) compared with control individuals. Moreover, patients with estrogen receptor\u2013positive\/progesterone receptor\u2013positive breast cancer were 15 times more likely to develop the autoimmune disorder Hashimoto thyroiditis compared with controls, which was statistically significant (P\u2005=\u2005.026).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study highlighted a strong association between breast cancer and thyroid disorders, particularly indicating a higher prevalence of hypothyroidism among individuals with breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/labmed\/lmaf024","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T06:34:38Z","timestamp":1745476478000},"page":"657-662","source":"Crossref","is-referenced-by-count":1,"title":["Association of thyroid disorders and breast cancer: a retrospective case-control study"],"prefix":"10.1093","volume":"56","author":[{"given":"Nadine","family":"Noubani","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Sciences, School of Health Professions, University of Texas Medical Branch , Galveston, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeza","family":"Esani","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, School of Health Professions, University of Texas Medical Branch , Galveston, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F M","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, School of Health Professions, University of Texas Medical Branch , Galveston, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8055-1512","authenticated-orcid":false,"given":"Carol A","family":"Carman","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, School of Health Professions, University of Texas Medical Branch , Galveston, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niti","family":"Vyas","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, School of Health Professions, University of Texas Medical Branch , Galveston, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"key":"2025112208220831600_CIT0001","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1138149","article-title":"Association between breast cancer and thyroid cancer risk: a two-sample Mendelian Randomization Study","volume":"14","author":"Tan","year":"2023","journal-title":"Front Endocrinol."},{"key":"2025112208220831600_CIT0002","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/aje\/152.10.950","article-title":"Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses\u2019 Health Study","volume":"152","author":"Colditz","year":"2000","journal-title":"Am J Epidemiol."},{"key":"2025112208220831600_CIT0003","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-6614-5-16","article-title":"The thyroid gland and the process of aging; what is new","volume":"5","author":"Gesing","year":"2012","journal-title":"Thyroid Res"},{"key":"2025112208220831600_CIT0004","volume-title":"Breast Cancer","author":"World Health Organization","year":"2023"},{"key":"2025112208220831600_CIT0005","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.eprac.2023.08.006","article-title":"Prevalence and trends of thyroid disease among adults, 1999-2018","volume":"29","author":"Zhang","year":"2023","journal-title":"Endocr Pract"},{"key":"2025112208220831600_CIT0006","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1590\/1414-431x20154445","article-title":"Gender, race and socioeconomic influence on diagnosis and treatment of thyroid disorders in the Brazilian Longitudinal Study of Adult Health (Elsa-Brasil)","volume":"48","author":"Olmos","year":"2015","journal-title":"Braz J Med Biol Res."},{"key":"2025112208220831600_CIT0007","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/ct.2022;34.286-289","article-title":"Thyroid hormones enhance the growth of estrogen receptor\u2013positive breast cancers","volume":"34","author":"Klubo-Gwiezdzinska","year":"2022","journal-title":"Clin Thyroidol"},{"key":"2025112208220831600_CIT0008","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1158\/1078-0432.ccr-20-2647","article-title":"Exogenous thyroid hormone is associated with shortened survival and upregulation of high-risk gene expression profiles in steroid receptor\u2013positive breast cancers","volume":"27","author":"Wahdan-Alaswad","year":"2021","journal-title":"Clin Cancer Res."},{"key":"2025112208220831600_CIT0009","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1515\/hmbci-2011-0130","article-title":"Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal a particle-promoted polypeptide in human breast cancer tissues","volume":"9","author":"Govindaraj","year":"2012","journal-title":"Horm Mol Biol Clin Investig"},{"key":"2025112208220831600_CIT0010","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/DDDT.S336643","article-title":"The role of progesterone receptors in breast cancer","volume":"16","author":"Li","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"2025112208220831600_CIT0011","volume-title":"Triple-negative breast cancer: details, diagnosis, and signs"},{"key":"2025112208220831600_CIT0012","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000325746","article-title":"HER2 Evaluation and its impact on breast cancer treatment decisions","volume":"15","author":"Goddard","year":"2012","journal-title":"Public Health Genomics"},{"key":"2025112208220831600_CIT0013","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10549-020-05675-6","article-title":"Association between thyroid gland diseases and breast cancer: a Case\u2013Control Study","volume":"182","author":"Bach","year":"2020","journal-title":"Breast Cancer Res Treat."},{"key":"2025112208220831600_CIT0014","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1089\/thy.2019.0426","article-title":"Breast cancer risk in postmenopausal women with a medical history of thyroid disorder in the Women\u2019s Health Initiative","volume":"30","author":"Weng","year":"2020","journal-title":"Thyroid."},{"issue":"5","key":"2025112208220831600_CIT0015","doi-asserted-by":"publisher","first-page":"R110","DOI":"10.1186\/bcr609","article-title":"Breast cancer in association with thyroid disorders","volume":"5","author":"Turken","year":"2003","journal-title":"Breast Cancer Res."},{"key":"2025112208220831600_CIT0016","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF03347458","article-title":"High prevalence of breast cancer in patients with benign thyroid diseases","volume":"34","author":"Muller","year":"2010","journal-title":"J Endocrinol Investig."},{"key":"2025112208220831600_CIT0017","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/thy.2012.0568","article-title":"Cancer risk in patients with Graves disease: A Nationwide Cohort Study","volume":"23","author":"Chen","year":"2013","journal-title":"Thyroid."},{"key":"2025112208220831600_CIT0018","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer\u2014epidemiology, risk factors, classification, prognostic markers, and current treatment strategies\u2014an updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers"},{"key":"2025112208220831600_CIT0019","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-030-20301-6_3","article-title":"Health and racial disparity in breast cancer","volume":"1152","author":"Yedjou","year":"2019","journal-title":"Adv Exp Med Biol."},{"key":"2025112208220831600_CIT0020","doi-asserted-by":"publisher","first-page":"336","DOI":"10.21037\/gs-20-878","article-title":"Thyroid disease is associated with an increased risk of breast cancer: a systematic review and meta-analysis","volume":"10","author":"Chen","year":"2021","journal-title":"Gland Surg"},{"key":"2025112208220831600_CIT0021","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.eprac.2020.09.007","article-title":"Risk of breast cancer in females with hypothyroidism: a nationwide, population-based, cohort study","volume":"27","author":"Huang","year":"2021","journal-title":"Endocr Pract"},{"key":"2025112208220831600_CIT0022","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13058-020-01337-z","article-title":"Incidence of hypothyroidism after treatment for breast cancer\u2014a Danish matched cohort study","volume":"22","author":"Falstie-Jensen","year":"2020","journal-title":"Breast Cancer Res."},{"key":"2025112208220831600_CIT0023","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12916-020-01690-y","article-title":"Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors","volume":"18","author":"Yang","year":"2020","journal-title":"BMC Med."},{"key":"2025112208220831600_CIT0024","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/EJE-15-0989","article-title":"Hypothyroidism and hyperthyroidism and breast cancer risk: a Nationwide Cohort Study","volume":"174","author":"S\u00f8gaard","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"2025112208220831600_CIT0025","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/s0140-6736(75)91006-5","article-title":"Breast cancer in patients with Hashimoto thyroiditis","volume":"306","author":"Itoh","year":"1975","journal-title":"The Lancet"},{"key":"2025112208220831600_CIT0026","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4158\/EP14445.OR","article-title":"Study of the prevalence of autoimmune thyroid disease in women with breast cancer","volume":"22","author":"Freitas","year":"2016","journal-title":"Endocr Pract"},{"key":"2025112208220831600_CIT0027","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2019.00344","article-title":"Molecular insights into the relationship between autoimmune thyroid diseases and breast cancer: a critical perspective on autoimmunity and ER stress","volume":"10","author":"Rahman","year":"2019","journal-title":"Front Immunol."},{"key":"2025112208220831600_CIT0028","doi-asserted-by":"publisher","first-page":"1185497","DOI":"10.3389\/fendo.2023.1185497","article-title":"The association between thyroid and breast cancers: a bidirectional mendelian randomization study","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"key":"2025112208220831600_CIT0029","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1158\/1055-9965.EPI-18-0877","article-title":"A linkage between thyroid and breast cancer: a common etiology","volume":"28","author":"Bolf","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/6\/657\/63449921\/lmaf024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/6\/657\/63449921\/lmaf024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T13:22:15Z","timestamp":1763817735000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/56\/6\/657\/8158261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,7]]},"published-print":{"date-parts":[[2025,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmaf024","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,6,7]]}}}